FOXA1 and prostate cancer: Accordingly, recent findings point towards the significant impact of FOXA1 in modulating nuclear steroid receptor activity in breast and prostate cancer, suggesting that FOXA1 may significantly contribute to pro-tumorigenic phenotype [32, 33].